Tufton Capital Management Bristol Myers Squibb CO Transaction History

Tufton Capital Management

  • $518 Million
  • Q1 2025

A detailed history of Tufton Capital Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tufton Capital Management holds 78,081 shares of BMY stock, worth $3.91 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares
78,081
Previous 79,395 1.66%
Holding current value
$3.91 Million
Previous $4.49 Million 6.06%
% of portfolio
0.92%
Previous 0.85%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 06, 2025
SELL
$53.9 - $63.11 $70,824 - $82,926
-1,314 Reduced 1.66%
78,081 $4.76 Million
Q4 2024

Feb 05, 2025
SELL
$51.92 - $59.94 $171,543 - $198,041
-3,304 Reduced 4.0%
79,395 $4.49 Million
Q3 2024

Nov 08, 2024
SELL
$39.66 - $51.75 $183,705 - $239,706
-4,632 Reduced 5.3%
82,699 $4.28 Million
Q2 2024

Jul 31, 2024
SELL
$40.25 - $52.99 $189,537 - $249,529
-4,709 Reduced 5.12%
87,331 $3.63 Million
Q1 2024

May 07, 2024
SELL
$47.98 - $54.4 $2.04 Million - $2.31 Million
-42,508 Reduced 31.59%
92,040 $4.99 Million
Q4 2023

Jan 31, 2024
SELL
$48.48 - $57.85 $280,602 - $334,835
-5,788 Reduced 4.12%
134,548 $6.9 Million
Q3 2023

Oct 30, 2023
SELL
$57.89 - $64.73 $145,767 - $162,990
-2,518 Reduced 1.76%
140,336 $8.15 Million
Q2 2023

Jul 28, 2023
SELL
$63.71 - $70.74 $162,333 - $180,245
-2,548 Reduced 1.75%
142,854 $9.14 Million
Q1 2023

Apr 19, 2023
SELL
$65.71 - $74.53 $59,598 - $67,598
-907 Reduced 0.62%
145,402 $10.1 Million
Q4 2022

Jan 26, 2023
SELL
$68.48 - $81.09 $192,291 - $227,700
-2,808 Reduced 1.88%
146,309 $0
Q3 2022

Oct 21, 2022
SELL
$0.13 - $76.84 $4,258 - $2.52 Million
-32,760 Reduced 18.01%
149,117 $10.6 Million
Q2 2022

Jul 20, 2022
SELL
$72.62 - $79.98 $42,410 - $46,708
-584 Reduced 0.32%
181,877 $14 Million
Q1 2022

Apr 25, 2022
SELL
$61.48 - $73.72 $166,180 - $199,265
-2,703 Reduced 1.46%
182,461 $13.3 Million
Q4 2021

Jan 28, 2022
BUY
$53.63 - $62.52 $50,144 - $58,456
935 Added 0.51%
185,164 $11.5 Million
Q3 2021

Oct 21, 2021
SELL
$59.17 - $69.31 $6,390 - $7,485
-108 Reduced 0.06%
184,229 $10.9 Million
Q2 2021

Jul 29, 2021
SELL
$61.91 - $67.42 $376,660 - $410,183
-6,084 Reduced 3.2%
184,337 $12.3 Million
Q1 2021

Apr 22, 2021
BUY
$59.34 - $66.74 $93,104 - $104,715
1,569 Added 0.83%
190,421 $12 Million
Q4 2020

Feb 01, 2021
BUY
$57.74 - $65.43 $308,504 - $349,592
5,343 Added 2.91%
188,852 $11.7 Million
Q3 2020

Oct 23, 2020
SELL
$57.43 - $63.64 $80,402 - $89,096
-1,400 Reduced 0.76%
183,509 $11.1 Million
Q2 2020

Jul 27, 2020
SELL
$54.82 - $64.09 $1,644 - $1,922
-30 Reduced 0.02%
184,909 $10.9 Million
Q1 2020

Apr 23, 2020
SELL
$46.4 - $67.43 $24,731 - $35,940
-533 Reduced 0.29%
184,939 $10.3 Million
Q4 2019

Jan 24, 2020
BUY
$49.21 - $64.19 $716,202 - $934,221
14,554 Added 8.52%
185,472 $11.9 Million
Q3 2019

Oct 25, 2019
SELL
$42.77 - $50.71 $70,570 - $83,671
-1,650 Reduced 0.96%
170,918 $8.67 Million
Q2 2019

Jul 26, 2019
BUY
$44.62 - $49.34 $243,045 - $268,754
5,447 Added 3.26%
172,568 $7.83 Million
Q1 2019

Apr 29, 2019
BUY
$45.12 - $53.8 $194,783 - $232,254
4,317 Added 2.65%
167,121 $7.97 Million
Q4 2018

Jan 28, 2019
SELL
$48.76 - $63.23 $122,826 - $159,276
-2,519 Reduced 1.52%
162,804 $8.46 Million
Q3 2018

Oct 26, 2018
SELL
$55.19 - $62.25 $104,309 - $117,652
-1,890 Reduced 1.13%
165,323 $10.3 Million
Q2 2018

Aug 06, 2018
SELL
$50.53 - $62.98 $61,090 - $76,142
-1,209 Reduced 0.72%
167,213 $9.25 Million
Q1 2018

Apr 23, 2018
SELL
$59.92 - $68.98 $204,027 - $234,876
-3,405 Reduced 1.98%
168,422 $10.7 Million
Q4 2017

Jan 26, 2018
SELL
$59.94 - $65.35 $16,903 - $18,428
-282 Reduced 0.16%
171,827 $10.5 Million
Q3 2017

Oct 20, 2017
BUY
$55.23 - $63.74 $9.51 Million - $11 Million
172,109
172,109 $11 Million

Others Institutions Holding BMY

# of Institutions
2,785
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $106B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tufton Capital Management Portfolio

Follow Tufton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email